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Ancestry speciﬁc associations of FTO gene
variant and metabolic syndrome
A longitudinal ARIC study
Dale S. Hardy, PhD, RD, CDEa,
∗
, Jane T. Garvin, PhD, ARNP, FNP-BCb, Tesfaye B. Mersha, PhDc,
Susan B. Racette, PhDd
Abstract
Cross-sectional studies indicate that the fat mass and obesity-associated (FTO) rs9939609 gene variant is associated with metabolic
syndrome (MetS) primarily in European ancestry. However, the association is not fully elucidated in African Americans.
We hypothesized that rs9939609 (AT = moderate-risk carriers or AA = high-risk carriers compared to TT = low-risk carriers) is
associated with MetS and its component risk factors over time; and that its association is ancestry-speciﬁc. A secondary hypothesis
was that higher levels of physical activity can decrease the deleterious effect of rs9939609 at higher body mass index (BMI).
Atherosclerosis Risk in Communities study repeated measures data from 4 visits (1987–1998) were obtained from the database of
Genotypes and Phenotypes for 10,358 participants (8170 Whites and 2188 African Americans) aged 45 to 64 years at baseline.
Guidelines for elevated blood pressure by the American College of Cardiology and American Heart Association Task Force were
updated within the MetS criteria. Risk ratios (RR) and 95% conﬁdence intervals from generalized estimating equations assessed
population-average risks.
MetS was present among 3479 (42.6%) Whites and 1098 (50.2%) African Americans at baseline, and 50.3% Whites and 57%
African Americans over 11-years of follow-up. Among MetS component risk factors, high waist circumference was most prevalent
among White AT (RR=1.07; 1.06–1.09) and AA (RR=1.12; 1.10–1.14) higher-risk carriers. High triglycerides were elevated among
African American AA high-risk carriers (RR=1.11; 1.02–1.21) compared to TT low-risk carriers. Over time, White AT-and AA higher-
risk carriers had 1.07 and 1.08-fold increase (P< .0001) in MetS risk. Physical activity had independent protective effects on MetS
among both races (P< .05). White AA high-risk carriers with normal BMI and low vs high physical activity had higher MetS risk (RR=
1.69; 1.25–2.30 and RR=0.68;0.53–0.87, respectively). In rs9939609  BMI physical activity interaction, White A-allele high-risk
carriers had lower MetS risk (RR=0.68; 0.53–0.87). AmongWhites, physical activity can lessen the effect of rs9939609 and high BMI
on risk for MetS.
Abbreviations: ACC = American College of Cardiology, AHA = American Heart Association, ARIC = Atherosclerosis Risk in
Communities study, BMI = body mass index, CI = conﬁdence interval, dbGaP = database of Genotypes and Phenotypes, dbSNP =
single nucleotide variant database, FTO = fat-mass-and-obesity-associated, HDL = high density lipoprotein cholesterol, MAF =
minor allele frequency, MetS = metabolic syndrome, QIC = Akaike Information Criterion, RR = risk ratio.
Keywords: ancestry, blood pressure, BMI, FTO rs9939609, longitudinal, metabolic syndrome, physical activity, race
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1. Introduction
Metabolic syndrome (MetS), an atherosclerotic disease precursor
deﬁned by the National Cholesterol Education Program Adult
Treatment Panel III as the clustering of 3 or more cardiovascular
metabolic risk factors,[1] approximately doubles the risk of type 2
diabetes, heart disease, stroke, cardiovascular mortality, and all-
cause mortality.[2–4] MetS is characterized by the presence of at
least 3 of 5 risk factors that include abnormal values for waist
circumference, blood pressure, fasting blood glucose, HDL
cholesterol, and triglycerides. These risk factors give an
indication of overall health and functioning of a patient’s
metabolic and circulatory systems, informing the clinician of
changes in health status over successive visits.[1] Updated
guidelines for blood pressure by the American College of
Cardiology (ACC) and American Heart Association (AHA) Task
Force[5] have lowered the blood pressure cut-points to designate
elevated systolic blood pressure as ≥120 mm Hg (previously
≥130 mm Hg) and elevated diastolic blood pressure as ≥80 mm
Hg (previously ≥85 mm Hg). Should the National Cholesterol
Education Program ATP III Guidelines adopt the lower blood
pressure cut-points, the prevalence of MetS may increase.
Reports using the old blood pressure cut-point forMetS (≥130/
85 mm Hg) show that approximately 34% of adults have
MetS,[2] with a higher prevalence in older adults and in those with
low levels of physical activity.[6] Physical activity of moderate-
intensity, performed 120 to 150minutes per week, can reduce the
risk of developing MetS, type 2 diabetes, cardiovascular disease,
and stroke.[2] Furthermore, lower levels of physical activity over a
20-year period were associated with elevated metabolic risk
factors contributing to MetS.[7] MetS increases with age,
correlates with dyslipidemia, and is most prevalent among those
with less than high school education.[2,8] Conﬂicting reports
show the age-adjusted prevalence of MetS in 2009 to 2010 was
similar among Whites and African Americans (21.8%),[2]
compared to a previous report that showed a disparity of
37.2% for Whites and 25.3% for African Americans.[9]
The fat mass and obesity-associated (FTO) rs9939609 gene
variant has the highest minor allele frequency compared to other
FTO variants. It is one of themost replicated and reported variant
in the GWAS catalog (6 studies in multiple ancestries). In
addition, it has comparable minor allele frequency (MAF) in our
study population: African (MAF=0.46), African American
(MAF=0.44), and European (MAF=0.43) ancestry samples.
Furthermore, rs9939609 is functionally important as shown in
HaploReg, including its role in Pou5f1 transcriptional activity.
FTO rs9939609 is the strongest genetic variant associated with
high body mass index (BMI), physical inactivity, and other
abnormal metabolic parameters in various populations.[10–25]
However, the relationship between rs9939609 and abnormal
metabolic traits (i.e., elevated waist circumference, hip circum-
ference, waist-to-hip ratio, blood pressure, and dyslipidemia) in
some studies became non-signiﬁcant after adjustment for BMI
due to its mediating effects.[17,22,25–29]
In a meta-analysis, rs9939609 variant was associated with an
11% increased risk of MetS inWhites.[30] A cross-sectional study
found an interaction between rs9939609 and physical activity on
adiposity inWhites andAfrican Americans.[24] In that study, each
additional copy of the high-risk rs9939609 A-allele was
associated with higher obesity-related anthropometric traits in
White and African American men. Another study that followed
Korean adults for 6 years did not ﬁnd an interaction between
rs9939609 andMetS. However, in that study, BMI rs9939609
interaction showed that participants with BMI ≥29kg/m2 had
higher risk for MetS.[31]
Thus, there is evidence that rs9939609, elevated BMI, and
physical inactivity are interrelated and associated with MetS in
cross-sectional studies.[11,12,15,19,21,24] However, these studies
have been performed primarily on populations with European
(White) ancestry, and associations with rs9939609 and MetS
have not been fully elucidated in other racial ancestry
populations, speciﬁcally African Americans. The aim of this
current study was to investigate whether FTO rs9939609 variant
is associated with increased risk for MetS and its component risk
factors from baseline to 11 years of follow-up in European
ancestry (Whites) and African Americans. We hypothesized that
rs9939609 variant increases the prevalence of MetS and its
component risk factors in Whites and African Americans over
time and that the magnitude of its association is ancestry-speciﬁc.
A secondary hypothesis was that higher levels of physical activity
can decrease the deleterious effect of rs9939609 variant in
participants with higher BMI.
2. Methods
2.1. Study population
Atherosclerosis Risk in Communities (ARIC) study data at
baseline (1987–1989) and 3 follow-up visits (1990–1992, 1993–
1995, and 1996–1998) were obtained from the database of
Genotypes and Phenotypes (dbGaP).[32] The ARIC study,
sponsored by the National Heart, Lung, and Blood Institute, is
a large-scale ongoing prospective cohort study being conducted
in 4 U.S. communities: Jackson, MS; Forsyth County, NC;
Minneapolis, MN; and Washington County, MD. ARIC was
designed to investigate the etiology and natural history of
atherosclerosis, as well as the causes of clinical atherosclerotic
diseases and their sequelae. Participants included White and
African American men and women who were 45 to 64 years old
at baseline.[33] Further design and sampling methods are
explained elsewhere.[34] All participants signed an informed
consent prior to participation in ARIC data collection. The
present study was approved by Morehouse School of Medicine
Social and Behavioral Institutional Review Board, Atlanta,
Georgia, USA.
2.2. Study variables
MetS was designated as the outcome variable, deﬁned according
to the modiﬁed National Cholesterol Education Program Adult
Treatment Panel III criteria[35] as clusters of ≥3 of the following
cardiovascular disease risk factors: waist circumference >102cm
in men or >88cm in women, systolic blood pressure ≥120 mm
Hg or diastolic blood pressure ≥80 mm Hg or on high blood
pressure medication, fasting blood glucose ≥100mg/dl or
diabetes diagnosis or on diabetes medication, HDL cholesterol
<40mg/dl in men or <50mg/dl in women, and triglyceride
level ≥150mg/dl or on lipid controlling medication.[2–4] BMI
(continuous variable) was calculated as weight in kilograms
divided by height in meters squared (kg/m2). Leisure-time sport
physical activity (continuous variable) was determined from the
validated Baecke self-administered questionnaire that gathered
information on habitual physical activity.[36] Leisure-time sports
physical activity data from baseline visit 1 (1987–1989) were
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carried forward to visit 2, and physical activity data from visit 3
was duplicated and carried forward to visit 4 (1993–1995)
because these data were collected only at visits 1 and 3. Education
level (3 level categorical variable) was collected at visit 1 only.
Age (continuous variable), gender, duration of study time (a
numerical sequential indicator for each visit (1 to 4)), and the ﬁrst
3 genetic principal components (continuous variable - used to
correct for population genetic admixture) were included as
additional covariates. FTO rs9939609 variant was presented as
the main predictor variable whose values were equal to the
number of copies of the high-risk A-allele under the additive
model (i.e., 0=TT low-risk, 1=AT moderate-risk, and 2=AA
high-risk carriers). BMI and leisure-time sport physical activity
were deﬁned as the interaction variables. All analyses were
stratiﬁed by race, which was self-reported as White or African
American. In other analyses that involved interaction, race, and
gender were the stratifying variables.
2.3. DNA extraction and genotyping
Based on dbSNP (single nucleotide variant database) data, the
FTO rs9939609 variant is in intron 1 of the FTO gene (Chr.
16q12.2). Genotyping of rs9939609 and the genetic principal
components were performed on whole blood using the TaqMan
assay (Applied Biosystems, Foster City, CA, USA), utilizing the
Affymetrix 6.0 single nucleotide variant array, and the Birdseed
calling algorithm[37] at the Broad Institute Center for Genotyping
and Analysis. Allele detection was carried-out using the ABI
Prism 7700 Sequence Detection System (Applied Biosystems). We
extracted FTO rs9939609 variant data from ARIC genome-wide
association study using the software Plink.[38]
2.4. Statistical analysis
The original participant sample included 14,928 participants at
baseline. We imputed missing observations on leisure-time sports
physical activity, BMI, and education level to augment our
sample, especially for African Americans. Imputations were<2%
of the original participant sample. To assimilate an ambulatory
population, participants were excluded from the analysis at
baseline and follow-up if they had mean arterial pressure <60
mm Hg (n=117), if there was a difference of <20 mm Hg
between systolic and diastolic blood pressures (n=31), if systolic
blood pressure was <80 mm Hg (n=11), or if diastolic blood
pressure was<45mmHg (n=110). Additional participants were
excluded if they had missing observations at baseline for MetS
component risk factors (n=315), FTO rs9939609 variant (n=
2179), or the ﬁrst 3 genetic principal components to control for
admixture (n=1807). Our ﬁnal models included 10,358
participants, of which 8170 (78.9%) were White and 2188
(21.1%) were African American. The Hardy–Weinberg equilib-
rium test for rs9939609 was performed using the Chi-Squared
goodness-of-ﬁt test forWhites and African Americans separately.
Generalized estimating equation regression analyses to estimate
population-average risks with risk ratios (RR) and 95%
conﬁdence intervals (CI) were used to evaluate the relationship
between FTO rs9939609 variant and risk for MetS and its
components over time. In these models, we examined the average
longitudinal change in MetS and its component risk factors with
repeated measures from visit 1 (baseline) to visit 4 (11 years)
separately for Whites and African Americans and by rs9939609
variant (i.e., AT moderate-risk carriers or AA high-risk carriers
compared to TT low-risk carriers). Among the repeated
responses at each visit, we used the exchangeable correlational
structure in the main models and the independent correlation
structure in stratiﬁed and interaction analyses as indicated by
Akaike Information Criterion testing. Robust standard errors
were used to approximate the variance correctly.[39]
All potential risk factors and covariates were tested for
inclusion in models. Each MetS component risk factor was
deﬁned as 0=value in the desired healthy range and notmedically
treated or 1= risk value for MetS component or medically
treated. MetS component risk factors were summed to create the
MetS variable. Participants having at least 3 of the 5 MetS
component risk factors were identiﬁed as having MetS. In order
to choose parsimonious models for our study, we usedWald tests
in model building. We intentionally did not include covariates for
whether participants were current drinkers and current smokers,
following testing that demonstrated no signiﬁcant differences in
Wald tests estimates for rs9939609 between the model that
included these covariates and a model that did not. Pearson Chi-
Squared tests of hypothesis for independence for categorical
variables and One-way ANOVA test for continuous variables
were applied to examine differences in genotype distributions
with risk factors among each racial group separately. Current
drinker (yes/no) as presently drinks alcohol weekly, current
cigarette smoker (yes/no) as presently smokes cigarettes weekly,
type 2 diabetes (yes/no), coronary heart disease (yes/no), and
stroke (yes/no) were used to describe the sample (shown in
Table 1) but were not used in other analyses.
Parsimonious models for rs9939609 variant and MetS
adjusted for age, gender, physical activity level, education level,
duration of study time, and the ﬁrst 3 genetic principal
components to correct for population genetic admixture stratiﬁed
by Whites or African Americans were chosen as the ﬁnal models
for presentation in the main effects models. In analyses to
investigate the probability of either remaining free of MetS over
time at each visit, we calculated the time between study visits as
the midpoint of each interval (in years) plus the time contributed
from the preceding visit.
In stratiﬁcation models, we used normal BMI as BMI < 25.0
kg/m2, and overweight/obese as BMI ≥ 25.0kg/m2. Physical
activity (Baecke units, 1–5) was dichotomized at the breakpoint
for Whites as 1.6= low physical activity and >1.6=high
physical activity, and for African Americans as 2.1= low
physical activity and >2.1=high physical activity. To test the
3-way interaction of rs9939609 variant, BMI, and physical
activity (i.e., rs9939609  BMI  physical activity) by race, we
used available ARIC data as the linear combination of
rs9939609, BMI, and/or physical activity, adjusted for cova-
riates. All regression analyses were bootstrap with 10,000
repetitions. Statistical analyses were conducted using Stata MP,
version 15.0 (StataCorp, College Station, TX).
3. Results
3.1. Descriptive characteristics
At baseline (1987–1989), there were 8,170 Whites (3,479;
42.6%) and 2188 African Americans (1,098; 50.2%) with MetS
aged 45 to 64 years. The number (percent) of participants at
baseline who met the old MetS criteria that included blood
pressure cut-points of ≥130 mm Hg systolic and ≥85 mm Hg
diastolic was 3194 (37.1%) Whites and 1042 (47.67%) African
Hardy et al. Medicine (2020) 99:6 www.md-journal.com
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Americans. Using these older blood pressure criteria (i.e., ≥130/
≥85 mm Hg), the prevalence of MetS during the 11-year follow-
up period was 46.4% in Whites and 54.2% in African
Americans. In contrast, using the updated criteria for elevated
blood pressure (i.e., ≥120/≥80 mm Hg), the prevalence of MetS
was 50.3% inWhites and 57.0% in African Americans. The FTO
rs9939609 variant was found to be in Hardy–Weinberg
equilibrium (P> .05) in both racial groups.
Table 1 shows baseline characteristics of participants in our
study stratiﬁed by race and rs9939609 genotypes (TT= low risk,
AT=moderate risk, and AA=high risk). Genotype frequencies
were statistically different within both racial groups. In general,
the proportion of participants with normal BMI, BMI ≥ 30kg/
m2, females, current smokers, high waist circumference, type 2
diabetes, coronary heart disease, stroke/TIA, or MetS was
signiﬁcantly different between rs9939609 genotypes among
Whites. However, only coronary heart disease and MetS were
signiﬁcantly different between rs9939609 genotypes among
African Americans.
Figure 1 displays the 4 visits by number of MetS component
risk factors (0, 1, 2, 3, 4, and 5) by race and rs9939609
genotypes. African Americans accumulated a higher percent of
≥3 MetS component risk factors than Whites across visits, but
percentages among Whites were generally higher in the TT low-
risk carriers compare to AT and AA higher-risk carriers. More
speciﬁcally, across all visits from baseline to 11 years of follow-
up, a lower percentage of African American rs9939609 TT, AT,
and AA carriers had 0, 1, and 2MetS component risk factors and
a higher percent had 3 and 4 MetS component risk factors.
However, a smaller proportion of African Americans had 5MetS
component risk factors than Whites. As MetS component risk
factors increased over time, the percent of participants with 0, 1,
and 2 MetS component risk factors became progressively smaller
across all visits, moreso in African Americans than Whites. The
prevalence of 3, 4, and 5MetS component risk factors (deﬁned as
having MetS) increased in both Whites and African Americans
across visits, with more African Americans having 3 or more
MetS component risk factors than Whites.
Figure 2 shows the proportion of participants with MetS and
without MetS and those who reversed from MetS to without
MetS. Across all visits, White AT and AA higher-risk carriers
generally had a higher proportion of MetS than TT low-risk
carriers over time. Among participants without MetS, a lower
percentage of Whites were AT and AA higher-risk carriers
compared to TT low-risk carriers, while for African Americans,
there is no clear pattern. African Americans who converted from
Table 1
Baseline characteristics of participants by race and FTO rs9939609 genotype: The ARIC study.
Whites (n=8170) African Americans (n=2188)
Characteristics TT (n=2905) AT (n=3893) AA (n=1372) TT (n=609) AT (n=1075) AA (n=504)
Genotype frequencies 35.6
∗
47.7
∗
16.8
∗
27.8x 49.1x 23.0x
Age (45–64 years) 54.4 (5.7) 54.3 (5.7) 54.3 (5.6) 53.5 (5.9) 53.4 (5.8) 53.7 (5.8)
Female (%) 52.4
∗
53.5< 49.6
∗< 60.9 61.5x 58.7x
Physical activity level (1–5 Baecke units) 2.5 (0.8) 2.5 (0.8) 2.6 (0.8) 2.2 (0.7) 2.1 (0.7) 2.2 (0.7)
Body mass index (kg/m2) 26.7 (4.6) 27.1 (4.8) 27.7 (5.1) 29.7 (6.3) 29.7 (6.0) 29.8 (5.8)
Underweight (%) 0.8
∗
0.8< 0.4
∗< 0.8x 1.0£ 0.6x£
Normal weight (%) 39.6
∗
35.4
∗
32.9∗ 20.5x 19.9 18.0x
Overweight (%) 39.6 41.2 39.3 39.2 37.8 39.1
Obese (%) 20.0
∗
22.8
∗
27.4
∗
39.5 41.4 42.4
Current smoker (%) 25.0
∗
24.7< 22.9
∗< 27.8 31.1 31.2
Current drinker (%) 66.0 66.8 66.8 32.2 34.7 33.3
Education level (%)
< High school (%) 14.7 15.5 14.5 41.5 39.4 41.3
High school or vocational school graduate
or some college education (%)
46.1
∗
44.2
∗
45.0 26.6 27.6 29.0
≥College graduate (%) 39.2 40.3 40.5 31.9 33.0x 29.8x
Waist circumference (cm) 95.22 (12.95)
∗
96.30 (13.26)
∗
97.90 (13.73)
∗
99.8 (15.1) 99.6 (15.0) 99.5 (14.9)
Systolic blood pressure (mm Hg) 118.6 (17.1) 118.7 (16.5) 119.2 (16.8) 129.1 (20.7) 128.5 (20.6) 129.0 (21.8)
Diastolic blood pressure (mm Hg) 71.7 (9.7) 71.9 (9.7) 72.3 (9.8) 80.3 (11.7) 79.8 (12.3) 79.5 (11.9)
Fasting blood glucose (mg/dl) 104.6 (30.9) 105.2 (29.4) 105.7 (31.7) 119.3 (60.7) 117.4 (55.7) 118.2 (52.9)
HDL cholesterol (mg/dl) 50.9 (16.8) 50.5 (16.7) 50.1 (16.8) 54.1 (17.6) 54.4 (16.7) 54.1 (16.9)
Triglyceride level (mg/dl) 134.2 (89.8) 140.3 (99.4) 136.0 (84.1) 118.8 (96.3) 112.4 (59.1) 123.4 (111.7)
Diabetes (%) 7.7∗ 9.1∗ 10.1∗ 21.0 19.5 20.2
Coronary heart disease (%) 5.2∗ 5.2< 6.3
∗< 4.4x 4.7x 5.6x
Stroke/TIA (%) 14.7
∗< 16.7
∗
17.7< 14.0 15.4 16.5
Metabolic syndrome (%) 39.8
∗
43.8
∗
45.1
∗
52.6x
∗
49.2
∗
49.4x
Values are means (SD) unless otherwise indicated.
ARIC = Atherosclerosis Risk in Communities study, BMI = body mass index, HDL = high density lipoprotein cholesterol.
%, percent of sample. All other variable results are means.
Current drinker, presently drinks alcohol weekly; current smoker, presently smokes cigarettes weekly.
Underweight (BMI < 18.5 kg/m2), Normal weight (BMI: 18.5–24.9 kg/m2), Overweight (BMI: 25.0–29.9 kg/m2), and Obese (BMI ≥ 30kg/m2) were calculated as percentages of total BMI.
Bold, means or proportions that were statistically different at P < .05.
∗<P value< .05 compared TT, AT, and AA genotypes among Whites.
x,£P value< .05 compared TT, AT, and AA genotypes among African Americans.
P values for proportions of categorical variables among FTO rs9939609 genotypes were calculated using Pearson Chi-Squared tests of hypothesis for independence for categorical variables and One-way ANOVA
for differences between means of continuous variables.
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Figure 1. Percent of participants within TT, AT, and AA genotypes at baseline and over time with MetS component risk factors (i.e., high waist circumference, high
blood pressure, high fasting blood glucose, low HDL (high density lipoprotein) cholesterol, and high triglycerides) in the ARIC study.
Figure 2. Percentage of participants within TT, AT, and AA genotypes at baseline (visit 1) and through 11 years of follow-up (visit 4) who remained free of metabolic
syndrome (2 risk factors), those who remained with metabolic syndrome (≥3 risk factors), those who converted from having metabolic syndrome to not having
metabolic syndrome (i.e., decreased from ≥3 risk factors to 2 risk factors), and those with converted from without metabolic syndrome to having metabolic
syndrome (i.e., increased from 2 risk factors to ≥3 risk factors) in the ARIC study. X-axis description for time in study: Baseline (visit 1); 5 years (end of visit 2); 8
years (end of visit 3); 11 years (end of visit 4).
Hardy et al. Medicine (2020) 99:6 www.md-journal.com
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having MetS to not having MetS were more likely to be AT and
AA higher-risk carriers than TT low-risk carriers.
Figure 3 displays the longitudinal changes in metabolic
syndrome across time, by race, for those who remained free of
MetS and ﬁrst conversion to MetS at each visit. At time zero, all
participants were free of MetS. However, with time, participants
converted to MetS such that at about 3 years, all White AA high-
risk carriers converted to MetS; 86% of AT moderate-risk
carriers and 55% of TT low-risk carries converted to MetS.
Among African Americans at about 3 years into the study, nearly
all TT low-risk carriers converted to MetS; 65% of AT and 86%
of AA higher-risk carriers converted to MetS. There was no clear
relationship with FTO rs9939609 genotypes among African
Americans, unlike among Whites. In Figure 3A and 3B, the log
rank test for equality in survival was not signiﬁcantly different
between genotypes by race.
3.2. FTO rs9939609 polymorphism and MetS component
risk factors
Table 2 shows the 5 components of MetS. Among the 5 MetS
components, FTO rs9939609 variant was associated with the
highest magnitude of risk for higher waist circumference in
Whites but not in African Americans. In general, White
participants with elevated waist circumference who had 2
high-risk alleles (AA carriers) had a higher risk (Risk Ratio
(RR)=1.12; 95% conﬁdence interval: 1.10–1.14) than those
with 1 high-risk allele (AT-allele carriers; RR=1.07; 1.06–1.09).
Whites who carry the A-allele (AT and AA genotypes) had 6%
higher risk (RR=1.06; 1.05–1.07) for elevated waist circumfer-
ence. Likewise, we observed small signiﬁcant associations with
elevated blood pressure, high fasting blood glucose, low HDL
cholesterol and high triglyceride levels for AA and AT higher-risk
carriers compared to TT low-risk carriers among Whites
(P< .05). These main-effects relationships were observed only
for high triglyceride levels among African Americans AA high-
risk carriers over time (RR=1.11; 1.02–1.21)
3.3. FTO rs9939609 variant and MetS
Among Whites in main effects models, the FTO rs9939609
variant was signiﬁcantly associated with small increases in risk
for MetS over time after adjusting for covariates (Table 3).
Whites with 1 high-risk allele (AT moderate-risk carriers) and 2
high-risk alleles (AA high-risk carriers) had 1.07 and 1.08-fold
increase in the risk for MetS (P< .05) over 11 years of follow-up.
Among Whites, BMI nulliﬁed the effect estimates of FTO
rs9939609 onMetS and therefore was not included in the models
in Table 3. Statistically signiﬁcant effects were not seen among
African Americans.
One of the underlying reasons for assessing dominant and
recessive modes of inheritance is to see whether participants with
at least 1 high-risk allele (dominant mode) or 2 high-risk alleles
(recessive mode) have an increased risk for MetS. We used the
method of the QIC to select the best ﬁtting model. Because
generalized estimating equation is based on a correlation
structure, the correlation matrix had the smallest Akaike
Information Criterion (QIC) value across the different equations
in the main models. In stratiﬁed models with BMI and physical
activity, the independent correlation structure had the lowest
QIC among different correlational structures and this was used as
the preferred correlational structure in stratiﬁed models. In main
models, we compared the additive A-allele, dominant and
recessive equations, for Whites and African Americans separate-
ly. For Whites, the values were: additive A-allele mode QIC=
7109.193, dominant mode QIC=7158.258, and recessive mode
QIC=7118.232. For African Americans, the corresponding
values were: additive A-allele mode QIC=6115.160, dominant
Figure 3. Estimated probability by race for those who remained free of metabolic syndrome (2 risk factors) at each visit. Log rank test showed no signiﬁcances
differences in survival functions between FTO rs9939609 (TT, AT, and AA carriers) for Whites (P= .686) and African Americans (P= .334). Time in study (Years): 0=
baseline (visit 1), 5=end of visit 2, 8=end of visit 3, 11=end of visit 4.
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modeQIC=6124.590, and recessive modeQIC=6116.776. Our
results suggest that the additive A-allele QICwas the smallest, but
differences within races were small.
3.4. FTO rs9930609, BMI, and physical activity in relation
to MetS
Table 4 shows the effects of high and low levels of BMI and
physical activity on MetS by race. Among Whites, we observed
mostly small effects for FTO rs9939609 onMetS for overweight/
obese participants. Within strata of high and low physical
activity, participants with low physical activity level had higher
risks for MetS than participants who reported high physical
activity. The risk was higher for AT carriers, but the conﬁdence
intervals were very wide, indicating imprecision of the estimate,
most likely due to small sample size. Most importantly, only the
overweight/obese category and low and high physical activity
categories among Whites met Bonferroni correction for multiple
testing. Among African Americans, there were no statistically
signiﬁcant effects for high or low physical activity or for
overweight or obese categories. Only the FTO rs9939609 BMI
interaction in Whites was statistically signiﬁcant.
Figure 4 shows the combinations of stratiﬁcations of FTO
rs9939609, low and high BMI, and low and high physical activity
on MetS. Among Whites with normal BMI and low physical
activity, higher risks for MetS were seen among FTO rs9939609
Table 2
FTO rs9939609 and increase risk in metabolic syndrome component risk factors by race over time in the ARIC study.
Risk ratio (95% Conﬁdence interval)
Characteristics Whites (n=8170) African Americans (n=2188)
FTO rs9939609: A vs TT
∗
High waist circumference (>102/>88cm men/women) 1.06 (1.05–1.07) 1.00 (0.99–1.02)
Elevated blood pressure (≥120/80 mm Hg or HTN meds) 1.02 (1.01–1.03) 0.99 (0.98–1.00)
High fasting blood glucose (≥100 mg/dl, T2DM dx, DM meds) 1.02 (1.00–1.03) 1.00 (0.98–1.01)
Low HDL cholesterol (<40/<50 mg/dl men/women 1.02 (1.01–1.03) 0.97 (0.91–1.03)
High triglyceride level (≥150 mg/dl) 1.03 (1.01–1.05) 1.05 (1.01–1.10)
FTO rs9938609: AT vs TT£ (n=6798) (n=1684)
High waist circumference (>102/>88cm men/women) 1.07 (1.06–1.09) 1.01 (0.99–1.04)
Elevated blood pressure (≥120/80 mm Hg or HTN meds) 1.03 (1.01–1.04) 0.99 (0.97–1.01)
High fasting blood glucose (≥100 mg/dL, T2DM dx, DM meds) 1.04 (1.02–1.06) 0.99 (0.96–1.02)
Low HDL cholesterol (<40/< 50 mg/dl men/women 1.03 (1.01–1.06) 0.96 (0.86–1.07)
High triglyceride level (≥150 mg/dl) 1.05 (1.03–1.08) 1.03 (0.95–1.11)
FTO rs9939609: AA vs TTx (n=4277) (n=1113)
High waist circumference (>102/>88cm men/women) 1.12 (1.10–1.14) 1.01 (0.98–1.04)
Elevated blood pressure (≥120/80 mm Hg or HTN meds) 1.03 (1.01–1.05) 0.99 (0.97–1.01)
High fasting blood glucose (≥100 mg/dl, T2DM dx, DM meds) 1.03 (1.01–1.05) 0.99 (0.96–1.03)
Low HDL cholesterol (<40/< 50 mg/dl men/women 1.03 (1.01–1.06) 0.94 (0.82–1.07)
High triglyceride level (≥150 mg/dl) 1.05 (1.02–1.09) 1.11 (1.02–1.21)
Bold indicates P values< .05.
Additive model: A vs TT
∗
, Comparison for higher-risk participants with at least 1 high-risk A-allele compared to low-risk participants with 2 low-risk alleles.
AT vs TT£, Comparison for moderate-risk participants with 1 high-risk A-allele compared to low-risk participants with 2 low-risk alleles.
AT vs TT£, Comparison for high-risk participants with 2 high-risk A-alleles compared to low-risk participants with 2 low-risk alleles.
DM = diabetes mellitus, dx = diagnosis, HDL = high density lipoprotein, HTN = high blood pressure, T2DM = type 2 diabetes.
Model: Each component of metabolic syndrome was regressed on age, gender, physical activity (sports Baecke domain), education level, duration of study time, and ﬁrst 3 genetic principle components to control
for population admixture separately for Whites and African Americans using generalized estimating equation analyses.
Table 3
FTO rs9939609 and longitudinal changes in metabolic syndrome by race over time in the ARIC study.
Risk ratio (95% Conﬁdence interval)
Characteristics Whites (n=8170) African Americans (n=2188)
FTO rs9939609 variant
Additive model: A vs TT# 1.04 (1.03–1.06) 0.99 (0.97–1.01)
AT vs TT£ 1.07 (1.05–1.09) 0.99 (0.96–1.02)
AA vs TTx 1.08 (1.05–1.10) 0.99 (0.95–1.03)
Dominant model: AT+AA vs TT< 1.03 (1.01–1.06) 0.99 (0.96–1.03)
Recessive model: AA vs AT+TT€ 1.07 (1.06–1.09) 0.99 (0.96–1.02)
Bold indicates P values< .05.
Additive model: A vs TT#, Comparison for higher-risk participants with at least 1 high-risk A-allele compared to low-risk participants with 2 low-risk alleles.
AT vs TT£, Comparison for moderate-risk participants with 1 high-risk A-allele compared to low-risk participants with 2 low-risk alleles.
AA vs TTx, Comparison for high-risk participants with 2 high-risk A-alleles compared to low-risk participants with 2 low-risk alleles.
<Comparison for AT and AA higher-risk participants together with 1 and 2 high-risk A-alleles compared to low-risk participants with 2 low-risk alleles.
€Comparison for higher-risk participants with 2 high-risk A-alleles compared to lower-risk participants with 1 and 2 low-risk alleles.
Main effects models: metabolic syndrome was regressed on age, gender, physical activity (Baecke sports domain), education level, duration of study time, and ﬁrst 3 genetic principle components to control for
population admixture separately for Whites and African Americans using generalized estimating equation analyses. These analyses did not include BMI.
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higher-risk carriers. However, a high physical activity level was
protective in participants with normal BMI. Among Whites
reporting a high physical activity level who were overweight or
obese, slightly higher risks were seen. Among African Americans,
most risks were not signiﬁcant, except that AT moderate-risk
carriers with normal BMI and low physical activity had a 1.46-
fold increased risk for MetS (RR=1.46; 1.00–2.13). However,
the conﬁdence interval was wide, indicating imprecision, and the
lower end bordering non-signiﬁcance.
Figure 5A and 5B show the effect estimates of the variables
and their interactions adjusted for covariates and other
interaction terms in relation to MetS. The highest risks were
seen among Whites for the effect of FTO rs9939609 alone in
higher-risk carriers. In both racial groups, each additional BMI
unit was associated with small increases in risk for MetS.
However, physical activity alone was independently protective
of MetS in FTO rs9939609. Among Whites, the protective
effects of physical activity on MetS remained signiﬁcant even
after Bonferroni correction for multiple testing when we
compared risks for FTO rs9939609  BMI vs FTO
rs9939609  BMI  physical activity in AT moderate-risk
carriers. Statistically signiﬁcant effects were less common
among African Americans.
4. Discussion
We observed that the prevalence of MetS in the ARIC population
was 50.3% in Whites and 57% in African Americans using the
updated criteria for elevated blood pressure (≥120/≥80 mmHg),
compared to 46.4% in Whites and 54.2% in African Americans
when using the older criteria (≥130/≥85 mm Hg). Among MetS
component risk factors, waist circumference was the most
prevalent among Whites with AT and AA genotypes. FTO
rs9939609 variant was signiﬁcantly associated with high
triglyceride level in African Americans. Our ﬁndings show that
FTO rs9939609 variant had small contributions to increased risk
for MetS in Whites in the main effects models. Among Whites,
high levels of physical activity were protective against deleterious
Table 4
Associations between FTO rs9930609 and MetS over time stratiﬁed by BMI or physical activity and race in the ARIC study.
Risk ratio (95% Conﬁdence interval) P for interaction
Model Normal weight Overweight/obese FTO rs9939609  BMI
Whites (n=8170)
Additive model: A vs TT# 0.99 (0.94–1.03) 1.03 (1.01–1.04)
∗
.007
AT vs TT£ 1.06 (1.00–1.14) 1.04 (1.02–1.06)
∗
<.001
AA vs TTx 0.92 (0.84–1.02) 1.05 (1.02–1.07)
∗
.062
Dominant model: (AT+AA vs TT)< 0.89 (0.82–0.98)
∗
1.02 (1.00–1.04) .771
Recessive model: (AA vs AT+TT)€ 1.03 (0.97–1.10) 1.04 (1.02–1.06)
∗
.001
African Americans (n=2188)
Additive model: A vs TT# 1.13 (0.98–1.30) 0.99 (0.96–1.01) .544
AT vs TT£ 1.38 (1.05–1.81)
∗
0.98 (0.94–1.03) .911
AA vs TTx 1.29 (0.93–1.78) 0.98 (0.93–1.03) .509
Dominant model: (AT+AA vs TT)< 1.03 (0.80–1.32) 0.98 (0.94–1.03) .408
Recessive model: (AA vs AT+TT)€ 1.35 (1.04–1.75) 0.98 (0.94–1.02) .840
Low physical activity High physical activity FTO rs9939609 
physical activity
Whites (n=8170)
Additive model: A vs TT# 1.07 (1.03–1.12)
∗
1.04 (1.02–1.06)
∗
.162
AT vs TT£ 1.07 (1.00–1.14) 1.08 (1.05–1.11)
∗
.934
AA vs TTx 1.15 (1.06–1.25)
∗
1.07 (1.03–1.11)
∗
.089
Dominant model: (AT+AA vs TT)< 1.11 (1.03–1.19)
∗
1.03 (0.99–1.06) .051
Recessive model: (AA vs AT+TT)€ 1.09 (1.03–1.16)
∗
1.07 (1.05–1.10)
∗
.597
African Americans (n=2188)
Additive model: A vs TT# 1.00 (0.97–1.04) 0.99 (0.95–1.03) .326
AT vs TT£ 1.01 (0.95–1.08) 0.99 (0.93–1.06) .390
AA vs TTx 1.00 (0.93–1.08) 0.99 (0.91–1.07) .339
Dominant model: (AT+AA vs TT)< 0.99 (0.93–1.06) 0.99 (0.92–1.06) .560
Recessive model: (AA vs AT+TT)€ 1.01 (0.95–1.07) 0.99 (0.93–1.06) .308
BMI = body mass index, MetS = metabolic syndrome.
Bold indicates P value< .05.
∗
Bonferroni correction for multiple comparisons was calculated as P value: .05/2= .025.
Main effects models: metabolic syndrome was regressed on age, gender, physical activity (Baecke sports domain), education level, duration of study time, and ﬁrst 3 genetic principle components to control for
population admixture stratiﬁed by BMI (normal or overweight/obese) and race (Whites or African Americans) using generalized estimating equation analyses.
Normal weight, BMI<25.0 kg/m2; Overweight or obese, BMI ≥ 30.0 kg/m2.
Physical activity was determined using the Baecke questionnaire (values range from 1 to 5 Baecke units). The results were dichotomized for Whites as 1.6= low physical activity and >1.6=high physical
activity, and for African Americans as 2.1= low physical activity and >2.1=high physical activity.
Additive model: A vs TT#- Comparison for higher-risk participants with at least 1 high-risk A-allele compared to low-risk participants with 2 low-risk alleles.
AT vs TT£, Comparison for moderate-risk participants with 1 high-risk A-allele compared to low-risk participants with 2 low-risk alleles.
AA vs TTx, Comparison for high-risk participants with 2 high-risk A-alleles compared to low-risk participants with 2 low-risk alleles.
Dominant model: (AT+AA vs TT)<, Comparison for AT and AA higher-risk participants together with 1 and 2 high-risk A-alleles compared to low-risk participants with 2 low-risk alleles.
Recessive model: (AA vs AT+TT)€, Comparison for higher-risk participants with 2 high-risk A-alleles compared to lower-risk participants with 1 and 2 low-risk alleles.
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effect of FTO rs9939609 onMetS, regardless of whether they had
normal BMI or were overweight or obese.
In other studies, de Luis et al[15] found that females with the
rs9939609 TT low-risk variant without MetS but who were
obese had higher levels of insulin resistance, insulin, and
triglycerides using the old MetS criteria with higher cut-points
for blood pressure. It is likely, however, that some participants in
that study who had<3MetS risk factors would be categorized as
having MetS using the updated criteria for elevated blood
pressure.
Al-Attar et al[19] found that the FTO rs9939609 variant was
associated with MetS in a non-White population, a ﬁnding that
was not observed in our study, possibly due to relatively small
sample size of African Americans. The prevalence of MetS is
known to increase with rising BMI. Similar to the Korean study
by Biak et al[31] we found that BMImodiﬁed the effect of the FTO
rs9939609 variant onMetS over time inWhites. The interactions
of rs9939609 variant with BMI increased the risk ratios above
that of the main effects models among Whites. However, among
Whites, the risk ratios became protective when physical activity
was included in the interaction model (rs9939609  BMI 
physical activity). Oyeyemi et al found that FTO rs9939609 
physical activity interaction lowered the risk of overweight/
obesity and increasing BMI in a Nigerian population.[40]
Rampersaud et al[23] found that physical activity blunted the
effects of obesity in an Amish population. In another ARIC study
analysis, Demerath et al[24] found an interaction with FTO
rs9939609 variant and physical activity on BMI, waist
circumference, and skinfold thickness among White and African
American men. Moreover, Demerath et al[24] and Andreasen
et al[22] found that high physical activity levels decreased the
effect of rs9939609 variant on body fat accumulation and
adiposity in their cross-sectional studies. Like Demerath et al[24]
we also observed interactions with rs9939609 variant, BMI and
physical activity on risk of MetS over time in the ARIC sample,
but among Whites only. Furthermore, the overall effect of high
levels of physical activity had protective independent effects on
MetS in both racial groups (P< .05). The risks for MetS were
highest among Whites for the independent effect of FTO
rs9939609 in higher-risk carriers. Each additional unit of BMI
had small increases in risk forMetS, such that a BMI of 25 and 30
kg/m2 would convey relative risks of 1.79 (1.40–2.28) and 2.01
(1.50–2.69), respectively. However, higher levels of physical
activity had independent protective effects against MetS in both
Figure 4. Associations of FTO rs9930609, BMI, and Physical Activity in Relation to MetS. overwt, overweight. Normal weight, BMI < 25.0kg/m2; Overweight or
obese, BMI ≥ 25.0kg/m2. Physical activity was determined using the Baecke questionnaire (values range from 1 to 5 Baecke units). Physical activity was
dichotomized for Whites as1.6= low physical activity and>1.6=high physical activity, and for African Americans as 2.1= low physical activity and >2.1=high
physical activity.
∗
Bonferroni correction for multiple comparisons was calculated as P value: .05/2= .025. Metabolic syndrome was regressed on age, gender,
physical activity (Baecke sports domain), education level, duration of study time, and the ﬁrst 3 genetic principle components to control for population admixture
separately for Whites and African Americans using generalized estimating equation analysis. All models were stratiﬁed by combinations of high or low BMI or high or
low physical activity. The P values for interactions for FTO rs9939609  BMI  physical activity were as follow, Whites: A-allele P< .001, AT P= .558, AA P= .140,
dominant P= .002, and recessive P= .747; African Americans: A-allele P= .028, AT P= .060, AA= .010, dominant P= .039, and recessive P= .013.
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racial groups (P< .05) and blunted the adverse effects of higher
BMI.
An important aspect of our study was that we used an updated
deﬁnition of the MetS, based on the current blood pressure
guidelines, which were revised in 2017.[5] Use of the current
blood pressure guidelines (vs the older criteria) increased the
prevalence of MetS in Whites and African Americans from
41.4% to 49.4% at baseline and from 49.2% to 56.8% at the
follow-up time points.
We identiﬁed a few limitations in our study. The sample of
African Americans in the ARIC cohort was smaller than for
Whites, particularly after excluding participants with missing
values for covariates. This may have contributed to non-
signiﬁcant ﬁndings in our results. African Americans are reported
to have lower rates of MetS than Whites.[41] Despite ﬁnding
higher rates for MetS among African Americans than Whites in
our sample, we did not observe any signiﬁcant associations of
rs9939609 with MetS in the main effects models. Some reports
claim that the lack of association of FTO rs9939609 variant and
MetS among African Americans may be due to the differences in
linkage disequilibrium patterns and that this genetic effect may be
captured by different markers in Whites than African Ameri-
cans.[42] However, in our analysis, through interactions with BMI
and physical activity, we observed higher risks that were
statistically signiﬁcant for AT moderate risk carriers among
African Americans, but conﬁdence intervals were wide, which
demonstrated low statistical power or a chance ﬁnding. Our
analyses may also contain residual confounding due to the
Figure 5. A and B. Interactions between FTO rs9939609  BMI Physical activity in relation to MetS. Interaction models: Metabolic syndrome was regressed on
FTO rs9939609, age, gender, physical activity (Baecke sports domain), body mass index, education level, duration of study time, the ﬁrst 3 genetic principle
components to control for population admixture, and interactions for FTO rs9939609 BMI physical activity, for Whites and African Americans separately using
generalized estimating equation model.
∗
Bonferroni correction for multiple comparisons was calculated as P value: .05/4= .013.
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exclusion of dietary factors. Nonetheless, the effects we found
among Whites and African Americans in our longitudinal study
extended the results of cross-sectional studies.
In summary, these ﬁndings suggest that the interaction of FTO
rs9939609 variant and BMI can signiﬁcantly increase the risk for
MetS among Whites over time and that physical activity can
decrease these risks. Our ﬁndings also indicate that the
association of the FTO rs9939609 variant with MetS may be
ancestry-speciﬁc, which is supported by the lack of signiﬁcance
among African Americans in the ARIC sample. In addition, the
interactions of rs9939609 variant with BMI and physical activity
on MetS risk differed based on ancestry. The longitudinal aspect
of this study provides evidence for a genetic effect of the FTO
rs9939609 variant among people of European ancestry (Whites)
on risks for MetS, even after accounting for age, gender, physical
activity, education level, duration of follow-up time, and
population admixturegeneticbiases.Theobservation thatphysical
activity may attenuate the effect of the rs9939609 variant and
higher BMI on MetS risk adds to the well-documented beneﬁts of
physical activity and supports the recommendationsof the Physical
Activity Guidelines for Americans.[43] It will be important to
replicate these genetic analyses in future studies with a larger
sample of African Americans.
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